Cargando…

S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION

Detalles Bibliográficos
Autores principales:	Gill, Harry, Yim, Rita, Chin, Lynn, Lee, Paul, LI, Vivian, Au, Lester, Kit Garret Leung, Man, Kumana, Cyrus, Lam Kwong, Yok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428313/ http://dx.doi.org/10.1097/01.HS9.0000967444.46240.9a

Ejemplares similares

P493: ORAL-ATO/ATRA/ASCORBIC ACID (AAA)-BASED INDUCTION OR MAINTENANCE OF FIRST COMPLETE REMISSION IMPROVED OUTCOMES IN NEWLY DIAGNOSED APL: A MULTICENTRE ANALYSIS OF THE APL ASIAN CONSORTIUM (APLAC)
por: Gill, Harry, et al.
Publicado: (2023)

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
por: Gill, Harinder, et al.
Publicado: (2023)

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022)

The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
por: Chin, Lynn, et al.
Publicado: (2022)

Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
por: Kumana, Cyrus R., et al.
Publicado: (2020)

UK Experience of an Alternative ATO Dosing Regimen in APL
por: Russell, Nigel, et al.
Publicado: (2020)

KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα
por: Wang, Xinrui, et al.
Publicado: (2019)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
por: Ortaboz, Damla, et al.
Publicado: (2023)

APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973)

APL : a short course
por: Pakin, Sandra
Publicado: (1973)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO
por: Molinaro, Alessandro, et al.
Publicado: (2022)

MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation
por: Zhuang, L K, et al.
Publicado: (2014)

APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)

APL 76 Conference
por: Hunter, G Truman
Publicado: (1976)

International Conference on APL
por: Van der Linden, Gijsbert
Publicado: (1980)

Suppression of Inflammation and Arthritis by Orally Administrated Cardiotoxin from Naja naja atra
por: Chen, Cao-Xin, et al.
Publicado: (2015)

ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia
por: Long, Zi-Jie, et al.
Publicado: (2014)

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO‐based treatment
por: Loyaux, Romain, et al.
Publicado: (2023)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

APL programs for the mathematics classroom
por: Thomson, Norman D
Publicado: (1989)

Editorial: Welcome to APL Bioengineering
por: Cooper-White, Justin
Publicado: (2017)

Cuenta atrás
por: Hurwitz, Gregg Andrew
Publicado: (2004)

Hasta atrás
por: Escamilla Monroy, Ruth, et al.
Publicado: (2018)

Biophysical Analysis of Anopheles gambiae Leucine-Rich Repeat Proteins APL1A(1), APL1B and APL1C and Their Interaction with LRIM1
por: Williams, Marni, et al.
Publicado: (2015)

Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023)

Correction: Biophysical Analysis of Anopheles gambiae Leucine-Rich Repeat Proteins APL1A(1), APL1B and APL1C and Their Interaction with LRIM1
Publicado: (2015)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

An alpha-omega compiler for APL functions
por: Kirby, C R
Publicado: (1981)

Computing in statistical science through APL
por: Anscombe, Francis John
Publicado: (1981)

Dejados atrás : los chicos
por: Jenkins, Jerry B.
Publicado: (1999)

Atrás del viento /
por: Cerecedo, Eduardo, 1962-
Publicado: (1995)

THE SIGNIFICANCE OF ORAL ASCORBIC ACID IN PATIENTS WITH COVID-19
por: Patel, Manishkumar, et al.
Publicado: (2020)

Status of Serum and Salivary Ascorbic Acid in Oral Potentially Malignant Disorders and Oral Cancer
por: Bhat, Supriya, et al.
Publicado: (2017)

The curious case of HLA‐DR‐positive APL
por: Devi, Kanta, et al.
Publicado: (2020)

Differentiation Syndrome in Acute Leukemia: APL and Beyond
por: Woods, Ashley C., et al.
Publicado: (2023)

Editorial: Global excellence in oral health: Europe
por: Pavlic, V., et al.
Publicado: (2023)

El cuarto de atrás /
por: Martín Gaite, Carmen
Publicado: (1978)

La noche quedó atrás /
por: Valtin, Jan, 1904-1951
Publicado: (1961)

Cannot write session to /tmp/vufind_sessions/sess_9b1qul93dacdn3b054eroqn737